-
Rilpivirine, sold
under the
brand names Edurant and Rekambys, is a medication,
developed by Tibotec, used for the
treatment of HIV/AIDS. It is a second-generation...
- Cabotegravir/
rilpivirine, sold
under the
brand name Cabenuva, is a co-packaged
antiretroviral medication for the
treatment of HIV/AIDS. It
contains cabotegravir...
- Emtricitabine/
rilpivirine/tenofovir, sold
under the
brand name
Complera among others, is a fixed-dose
combination of
antiretroviral drugs for the treatment...
- elvitegravir/cobicistat/emtricitabine/tenofovir; (Stribild)) Emtricitabine/
rilpivirine/tenofovir
alafenamide (Odefsey) —
approved in the
United States in March...
-
intramuscular injection, as well as in an
injectable combination with
rilpivirine under the
brand name Cabenuva. It is an
integrase inhibitor with a carbamoyl...
- Dolutegravir/
rilpivirine, sold
under the
brand name Juluca, is a fixed-dose
combination antiretroviral medication for the
treatment of HIV/AIDS. It contains...
- contents.
Rilpivirine is best
absorbed under acidic conditions. Therefore,
rabeprazole would be
expected to
decrease the
absorption of
rilpivirine, decrease...
-
original on 28
February 2014.
Retrieved 23
February 2014. "Edurant-
rilpivirine hydrochloride tablet, film coated". DailyMed. 8 June 2020. Retrieved...
-
marketing authorizations for two new
antiretroviral (ARV) medicines,
rilpivirine (Rekambys) and
cabotegravir (Vocabria), to be used
together for the treatment...
-
indicated for PrEP]; and Vocabria/Cabenuva [when co-administered with
rilpivirine for HIV
treatment – in
partnership with
Janssen Pharmaceuticals]) Protease...
